Salactol Collodion אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

salactol collodion

dermal laboratories ltd - lactic acid; salicylic acid - collodion - 16.7%w/w +16.7 percent weight/weight - wart and anti-corn preparations

EPIOTIC EAR AND SKIN CLEANSER FOR DOGS AND CATS אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

epiotic ear and skin cleanser for dogs and cats

virbac (australia) pty ltd - s-lactic acid; salicylic acid - topical cream, ointment, paste, gel, lotion - s-lactic acid ungrouped active 25.0 mg/ml; salicylic acid phenol active 1.1 mg/ml - ear,nose,throat preps. - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - keratolytic or cleaning agent | otitis externa | acute canine otitis | associated with yeast &/or bac | biotin deficiency | brittle hoof | chronic canine otitis | cleansing agents | coat appearance | conditioning | conjunctivitis | cracked hoof | dry skin | flaking | galls | grooming aids | hoof conditioning | hoof moisturising | hopple chafes | itching | laminitis | malassezia pachydermatis | moisturising | otitis (canine) | pliability | psoriasis | scratches | skin cleanser | wart removal

AUGMENTIN- amoxicillin and clavulanate potassium tablet, film coated
AUGMENTIN- amoxicillin and clavulanate potassium powder, f ארצות הברית - אנגלית - NLM (National Library of Medicine)

augmentin- amoxicillin and clavulanate potassium tablet, film coated augmentin- amoxicillin and clavulanate potassium powder, f

dr. reddy's laboratories inc - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin anhydrous 250 mg - to reduce the development of drug‑resistant bacteria and maintain the effectiveness of augmentin (amoxicillin/clavulanate potassium) and other antibacterial drugs, augmentin should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. augmentin® is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*: caused by beta‑lactamase–producing isolates of haemophilus influenzae and moraxella catarrhalis . caused by beta‑lactamase–producing isolates of h. influenzae and m. catarrhalis . caused by beta‑lactamase–producing isolates of h. influenzae and m. catarr

AMOXICILLIN AND CLAVULANATE POTASSIUM tablet, film coated
AMOXICILLIN AND CLAVULANATE POTASSIUM powder, for suspension ארצות הברית - אנגלית - NLM (National Library of Medicine)

amoxicillin and clavulanate potassium tablet, film coated amoxicillin and clavulanate potassium powder, for suspension

dr. reddy's laboratories inc - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - amoxicillin anhydrous 250 mg - to reduce the development of drug‑resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium and other antibacterial drugs, amoxicillin and clavulanate potassium should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. amoxicillin and clavulanate potassium is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*: caused by beta‑lactamase–producing isolates of haemophilus influenzae and moraxella catarrhalis . caused by beta‑lactamase–producing isolates of h. influenzae and m. catarrhalis . caused by beta‑lactamase–pro

HIGHLIGHTS OF PRESCRIBING INFORMATION ארצות הברית - אנגלית - NLM (National Library of Medicine)

highlights of prescribing information

abbvie inc. - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg in 5 ml - depakene (valproic acid) is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. depakene (valproic acid) is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precautions (5.1) for statement regarding fatal hepatic dysfunction. because of the risk to the fetus of decreased iq, neurodevelopmental disorders , neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be used to treat women with epilepsy

EASYSTRIDE formic acid lactic concentrate ארצות הברית - אנגלית - NLM (National Library of Medicine)

easystride formic acid lactic concentrate

delaval - lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at) - lactic acid 146.7 g in 1 l

OXY-GARD- hydrogen peroxide, lactic acid, dodecyl benzene sulfonic acid solution ארצות הברית - אנגלית - NLM (National Library of Medicine)

oxy-gard- hydrogen peroxide, lactic acid, dodecyl benzene sulfonic acid solution

ecolab inc. - hydrogen peroxide (unii: bbx060an9v) (hydrogen peroxide - unii:bbx060an9v), dodecylbenzenesulfonic acid (unii: 60nsk897g9) (dodecylbenzenesulfonic acid - unii:60nsk897g9), lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at) - hydrogen peroxide 5 mg in 1 ml - directions: important: do not further dilute with water or mix with any other teat dips. if product in dip cup becomes visibly dirty, discard contents and replenish with fresh product. do not reuse or return any unused product to the original container. udder prep: when using an udder wash step before milking, make sure to wash teats with appropriate udder wash solution using proper cleaning procedures. teats should then be dried with single-service towels. directions for teat dipping pre-milk dipping: before each cow is milked, and using fresh oxy-gard, dip each teat full-length into the teat dip cup. wipe teats after dipping using single-service towels to avoid contamination of milk. post-milk dipping: using fresh oxy-gard, dip each teat full-length into the teat dip cup. do not wipe. allow to air dry. do not turn cows out in freezing weather until the product is completely dry. directions for teat spraying pre-milk spraying: before each cow is milked, and using fresh oxy-gard, spray entire teat. wipe

BUPRENORPHINE AND NALOXONE film ארצות הברית - אנגלית - NLM (National Library of Medicine)

buprenorphine and naloxone film

mylan pharmaceuticals inc. - buprenorphine hydrochloride (unii: 56w8mw3en1) (buprenorphine - unii:40d3scr4gz), naloxone hydrochloride dihydrate (unii: 5q187997ee) (naloxone - unii:36b82amq7n) - buprenorphine and naloxone sublingual film is indicated for treatment of opioid dependence. buprenorphine and naloxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support. buprenorphine and naloxone sublingual film is contraindicated in patients with a history of hypersensitivity to buprenorphine or naloxone as serious adverse reactions, including anaphylactic shock, have been reported [see warnings and precautions (5.9) ] . the data on use of buprenorphine, one of the active ingredients in buprenorphine and naloxone sublingual film, in pregnancy, are limited; however, these data do not indicate an increased risk of major malformations specifically due to buprenorphine exposure. there are limited data from randomized clinical trials in women maintained on buprenorphine that were not designed appropriately to assess the risk of major malformations [see data] . observational studies have reported on congenital malformations among buprenorphine-e

CHEM-STAR SENTINEL PLUS- hydrogen peroxide, lactic acid, dodecyl benzene sulfonic acid solution ארצות הברית - אנגלית - NLM (National Library of Medicine)

chem-star sentinel plus- hydrogen peroxide, lactic acid, dodecyl benzene sulfonic acid solution

meda inc. - hydrogen peroxide (unii: bbx060an9v) (hydrogen peroxide - unii:bbx060an9v), dodecylbenzenesulfonic acid (unii: 60nsk897g9) (dodecylbenzenesulfonic acid - unii:60nsk897g9), lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at) - directions: important: do not further dilute with water or mix with any other teat dips. if product in dip cup becomes visibly dirty, discard contents and replenish with fresh product. do not reuse or return any unused product to the original container. udder prep: when using an udder wash step before milking, make sure to wash teats with appropriate udder wash solution using proper cleaning procedures. teats should then be dried with single-service towels. directions for teat dipping pre-milk dipping: before each cow is milked, and using fresh chem-star sentinel plus, dip each teat full-length into the teat dip cup. wipe teats after dipping using single-service towels to avoid contamination of milk. post-milk dipping: using fresh chem-star sentinel plus, dip each teat full-length into the teat dip cup. do not wipe. allow to air dry. do not turn cows out in freezing weather until the product is completely dry. directions for teat spraying pre-milk spraying: before each cow is milked, and using fresh chem

BUPRENORPHINE AND NALOXONE film ארצות הברית - אנגלית - NLM (National Library of Medicine)

buprenorphine and naloxone film

mylan pharmaceuticals inc. - buprenorphine hydrochloride (unii: 56w8mw3en1) (buprenorphine - unii:40d3scr4gz), naloxone hydrochloride dihydrate (unii: 5q187997ee) (naloxone - unii:36b82amq7n) - buprenorphine and naloxone sublingual film is indicated for treatment of opioid dependence. buprenorphine and naloxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support. buprenorphine and naloxone sublingual film is contraindicated in patients with a history of hypersensitivity to buprenorphine or naloxone as serious adverse reactions, including anaphylactic shock, have been reported [see warnings and precautions (5.9)] . the data on use of buprenorphine, one of the active ingredients in buprenorphine and naloxone sublingual film, in pregnancy, are limited; however, these data do not indicate an increased risk of major malformations specifically due to buprenorphine exposure. there are limited data from randomized clinical trials in women maintained on buprenorphine that were not designed appropriately to assess the risk of major malformations [see data] . observational studies have reported on congenital malformations among buprenorphine-exp